Nov 14, 2022 | Company News, Genius Engage, Genius Suite
Genius vENGAGE: The Remote Verbal Consent for a Patient-Centric Clinical Trial Exom Group, a Clinscience company, is proud to announce the release of the first patient-centric “reliable & compliant” remote verbal consent for clinical trials (Genius vENGAGE). The...
Jan 15, 2022 | Company News, Genius Suite
Exom is proud to announce to being awarded the GHP Global Excellence Award by Global Health & Pharma as “Most Innovative Full-Service CRO – 2022” for our pioneering and cutting-edge use of technology (with our Genius SUITE™) in clinical trials to...
Mar 26, 2021 | Articles, Genius Suite
EXOM, is a globally acting full-service CRO (Contract Research Organization), founded in 2014 in Milan (Italy). Exom’s primary mission is to implement next-generation clinical trial 5.0 processes by exploiting innovative technologies and combining them with our...
Nov 30, 2020 | Case Study, Company News, Genius Suite
Digital technologies have been used in clinical studies for years. So far, however, they have been used very hesitantly by sponsors, study centers and CROs. Authorities have also been very hesitant to approve their use. The Covid-19 pandemic, however, has changed this...
Sep 17, 2020 | Articles, Clinical Trial News, Genius Suite
In the aftermath of the Covid-19 pandemic, there was a debate both on the limits of typical on-site monitoring visits and on whether alternative technology-based solutions should continue to be used, even under normal conditions. As known during the pandemic, the...
Jun 17, 2020 | Articles, Company News, Genius Suite
Exom Group Srl, in collaboration with Meteda Srl, announces the release of Genius FIRE Diabetes, the first large-scale eSource infrastructure operating in Europe for more efficient conduction of Clinical Trials in Diabetes. As is well known, Diabetes is one of the...
